Search - tctmd.com

Displaying 301 - 318 of 318

Sort: Relevancy | Date

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

May 10, 2011

News Daily News

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

May 03, 2011

News Daily News

The COURAGE Effect: Sustained Decline Seen in PCI for Stable Angina

April 25, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

April 15, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

April 11, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

April 04, 2011

News Conference News

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

April 03, 2011

News Daily News

BARI 2D: Prompt Revascularization Improves Angina Symptoms in Diabetics

April 01, 2011

News Daily News

Sponsors Pull the Plug on TRIGGER-PCI

March 18, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Industry News

Miracor reports successful completion of the ‘Prepare PICSO’ clinical trial

March 03, 2011

News Daily News

Steady Decline Seen in PCI Use Over Last Few Years

February 21, 2011

News Daily News

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

February 15, 2011

News Daily News

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

February 07, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

January 10, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

January 04, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.